Values (N=645) | |
---|---|
Baseline demographic and clinical variables | |
Age (years); mean±SD | 49±14 |
Female sex; n (%) | 331 (51%) |
Hispanic/Latino; n (%) | 56 (9%) |
APACHE III; mean±SD | 85±26 |
Race; n (%) | |
American Indian or Alaskan Native | 5 (1%) |
Asian | 8 (1%) |
White | 507 (77%) |
Black or African American | 104 (16%) |
Native Hawaiian or other Pacific Islander | 1 (<1%) |
Not reported | 17 (3%) |
Lung injury category; n (%) | |
Trauma | 32 (5%) |
Sepsis | 106 (16%) |
Multiple transfusion | 15 (2%) |
Aspiration | 72 (11%) |
Pneumonia | 387 (60%) |
Other | 38 (6%) |
Comorbidities; n (%) | |
Chronic dialysis | 14 (2%) |
Leukaemia (AML, CML, ALL, multiple myeloma) | 11 (2%) |
Non-Hodgkin's lymphoma | 5 (1%) |
Solid tumour with metastasis | 4 (1%) |
Immune suppression (within last 6 months) | 49 (8%) |
Hepatic failure (with coma or encephalopathy) | 3 (<1%) |
Cirrhosis | 24 (3%) |
Diabetes mellitus | 154 (24%) |
History of hypertension | 269 (42%) |
Prior myocardial infarction | 31 (5%) |
Congestive heart failure | 32 (5%) |
Peripheral vascular disease | 25 (4%) |
Prior stroke with sequelae | 10 (2%) |
Dementia | 3 (<1%) |
Chronic pulmonary disease | 73 (11%) |
Arthritis | 46 (7%) |
Peptic ulcer disease | 18 (3%) |
Variables in the primary analysis | |
Residence prior to hospitalisation; n (%) | |
Home independently | 589 (91%) |
Home with informal help | 36 (6%) |
Requiring professional help at home OR residence at healthcare facility | 20 (3%) |
AIDS; n (%) | 10 (2%) |
Current smoker at time of hospital admission; n (%) | 269 (42%) |
Body mass index at the time of hospital admission; mean±SD | 30±8 |
Outcome | |
EQ-5D; median (IQR) | 0.77 (0.51–0.83) |
ALL, acute lymphocytic leukemia; AML, acute myelogenous leukemia; CNL, chronic myelogenous leukemia.